1
Clinical Trials associated with GZR101-80 / Not yet recruitingPhase 2 在口服降糖药控制不佳、既往使用基础/预混胰岛素控制不佳的2型糖尿病患者中评价GZR101-80 注射液的疗效和安全性的多中心 II 期临床研究
[Translation] A multicenter Phase II clinical study to evaluate the efficacy and safety of GZR101-80 injection in patients with type 2 diabetes who are poorly controlled with oral hypoglycemic drugs and have previously been poorly controlled with basal/premixed insulin.
主要目的:以治疗16周后糖化血红蛋白(HbA1c)较基线的变化比较GZR101-80注射液与德谷门冬双胰岛素注射液(诺和佳®)或门冬胰岛素30注射液(诺和锐®30)在2型糖尿病患者的有效性。
[Translation] Primary objective: To compare the effectiveness of GZR101-80 injection with that of degludec and insulin aspart injection (Novogar®) or insulin aspart 30 injection (NovoRapid® 30) in patients with type 2 diabetes based on the change in glycated hemoglobin (HbA1c) from baseline after 16 weeks of treatment.
100 Clinical Results associated with GZR101-80
100 Translational Medicine associated with GZR101-80
100 Patents (Medical) associated with GZR101-80
100 Deals associated with GZR101-80